✦ LIBER ✦

Immunogenicity of CIGB-230, a therapeutic DNA vaccine preparation, in HCV-chronically infected individuals in a Phase I clinical trial

✍ Scribed by L. Alvarez-Lajonchere; N. H. Shoukry; B. Grá; Y. Amador-Cañizares; F. Helle; N. Bédard; I. Guerra; C. Drouin; J. Dubuisson; E. E. González-Horta; G. Martínez; J. Marante; Z. Cinza; M. Castellanos; S. Dueñas-Carrera

Book ID: 108886213
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 201 KB
Volume: 16
Category: Article
ISSN: 1352-0504
DOI: 10.1111/j.1365-2893.2008.01058.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I clinical trial of dendritic ce

A phase I clinical trial of dendritic cell immunotherapy in HCV-infected individuals

✍ Eric J. Gowans; Stuart Roberts; Kathryn Jones; Irene Dinatale; Philippe A. Latou 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 774 KB

42 A NOVEL VECTORIZED HCV THERAPEUTIC VA

42 A NOVEL VECTORIZED HCV THERAPEUTIC VACCINE (TG4040): RESULTS OF A PHASE I STUDY IN NAIVE PATIENTS CHRONICALLY INFECTED BY HCV

✍ F. Habersetzer; J.-P. Zarski; V. Leroy; M. Maynard-Muet; J.-P. Bronowicki; C. Fe 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Immunogenicity of a universal HIV-1 vacc

Immunogenicity of a universal HIV-1 vaccine vectored by DNA, MVA and CHADV-63 in a Phase I/IIA clinical trial

✍ NJ Borthwick, T Ahmed, A Rose, U Ebrahimsa, A Black, E Hayton, H Yang… 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 67 KB

Lessons from IAVI-006, a Phase I clinica

Lessons from IAVI-006, a Phase I clinical trial to evaluate the safety and immunogenicity of the pTHr.HIVA DNA and MVA.HIVA vaccines in a prime-boost strategy to induce HIV-1 specific T-cell responses in healthy volunteers

✍ A. Guimarães-Walker; N. Mackie; S. McCormack; T. Hanke; C. Schmidt; J. Gilmour; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 498 KB

Corrigendum to “Lessons from IAVI-006, a

Corrigendum to “Lessons from IAVI-006, a Phase I clinical trial to evaluate the safety and immunogenicity of the pTHr.HIVA DNA and MVA.HIVA vaccines in a prime-boost strategy to induce HIV-1 specific T-cell responses in healthy volunteers” [Vaccine 26 (2008) 6671–6677]

✍ A. Guimarães-Walker; N. Mackie; S. McCormack; T. Hanke; C. Schmidt; J. Gilmour; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 91 KB